$IT

Our AI knew it: +200%, these stocks smashed earnings and keep surging higher

Investing.com says Q2 earnings season lifted US stocks, with the S&P 500 recording a record close and the Dow topping 54,000. It highlights AI-selected picks and cites recent results for Gartner (IT), Inspire (INSP), Arm (ARM), First Solar (FSLR), and Intel (INTC), including EPS and revenue beats and raised guidance, plus valuation and margin metrics for Gartner and Arm.

Original reporting
Published Aug 5, 2026, 10:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 10:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$IT
Bullish
medium confidence
Mentioned
$IT · $INSP · $ARM · $FSLR · $INTC
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ITBullishMed
01

Why it matters

It highlights several companies’ reported EPS and revenue beats and, for Gartner, raised full-year guidance, implying potential upward estimate revisions and continued momentum.

02

Market read

Traders can use the cited earnings beats and Gartner’s guidance raise as near-term catalysts, but the article’s broader framing is marketing-heavy.

03

What to watch

It provides limited detail on guidance magnitude, margins sustainability, and any one-off items behind the beats, which can cap follow-through.

Relevance 4/10Novelty 4/10Timing: post-earnings, within the last week’s reported results

Background

The piece is a promotional InvestingPro/ProPicks AI marketing column claiming model-driven positioning ahead of Q2 earnings.

Company-level read

Ticker impact

$ITBullishMedium confidence
Context

Gartner reported Q2 adjusted EPS of $4.37 vs $3.76 consensus and raised full-year guidance across earnings, revenue, and cash flow.

Expected impact

Potential for continued post-earnings bid as guidance reduces downside risk.

Evidence & confidence

The article cites both a quantified beat and explicit full-year guidance increases, which typically drives re-rating if credible.

$INSPBullishMedium confidence
Context

Inspire Medical Systems reported Q2 EPS of $0.14 versus an expected loss of -$0.24 and revenue above expectations.

Expected impact

Likely follow-through buying over days to weeks if guidance commentary supports the beat.

Evidence & confidence

The text provides a clear EPS surprise magnitude and revenue beat, both of which are actionable for earnings-trend traders.

$ARMBullishMedium confidence
Context

Arm reported Q1 EPS of $0.45 vs $0.40 expected and revenue up 22% year-on-year to a record $1.29 billion.

Expected impact

Momentum could persist if investors extrapolate the growth rate into forward estimates.

Evidence & confidence

The article includes both EPS beat and a quantified revenue growth acceleration, a common driver of estimate revisions.

$FSLRBullishMedium confidence
Context

First Solar reported Q2 adjusted EPS of $3.92 vs $3.01 expected, with revenue of $1.06 billion.

Expected impact

Short-term upside bias is plausible given the magnitude of the beat.

Evidence & confidence

The article provides concrete EPS and revenue figures tied to the earnings release.

$INTCBullishMedium confidence
Context

Intel reported Q2 adjusted EPS of $0.42 vs $0.21 consensus and revenue up 25.4% year-on-year to $16.1 billion.

Expected impact

Potential for continued re-rating if the guidance and cash flow narrative holds.

Evidence & confidence

The text cites both a doubled EPS beat and a large revenue growth rate, which typically moves expectations.

Market effects

Broad-based earnings beats across software/IT services, medtech, semis, and industrial solar reinforce a risk-on earnings tape.

US-focused earnings season narrative supports US large-cap momentum.

AI and semiconductor demand framing (Arm) may spill over into global AI supply-chain sentiment.

Counterpoint

The article is heavily promotional and may overstate causality from model picks; price action could already reflect the earnings beats.

Key entities

  • Gartner

    Reported Q2 adjusted EPS beat and raised full-year guidance.

  • Inspire Medical Systems

    Reported Q2 EPS surprise and revenue above expectations.

  • Arm Holdings

    Reported Q1 EPS beat and record revenue with strong growth.

  • First Solar

    Reported Q2 adjusted EPS beat and revenue of $1.06B.

  • Intel

    Reported Q2 adjusted EPS beat and revenue up 25.4% YoY.

Related articles

$INTCMed

Intel Stock Jumps 7.7%; the $145 Target Still Needs a Foundry Customer

Intel's stock rose 7.7% to $108.80, driven by bullish analyst targets and potential manufacturing cooperation. Analysts set price targets ranging from $120 to $165, contingent on Intel securing external foundry customers. Q2 revenue grew 25% to $16.1B, but the foundry segment reported a $2.09B loss with minimal external revenue.

$INTCMed

Intel and SK Hynix Consider Joint US Memory Chip Venture

SK Hynix (KRX:000660, OTCPL:HXSCL) and Intel (NASDAQ:INTC) are reportedly discussing a potential US memory chip manufacturing venture. Options include leasing Intel's Ohio site or forming a joint venture. Intel faces construction delays and financial strain, while SK Hynix aims to meet US demand. Both companies have not confirmed any finalized agreements.

$ARMMed

Arm CEO: Chip Supply, Not Demand, Is Now the Real Constraint

Arm Holdings CEO Rene Haas stated on 16 September 2026 that chip manufacturing capacity, not demand, is the industry's primary constraint. He reiterated confidence in meeting a $2bn AGI CPU revenue target, up from previous guidance. Arm's shares rose 3.3% in pre-market trading. Q2 2026 revenue reached $1.29bn, up from $1.05bn a year earlier, with net income more than doubling to $270m.